Promega to Distribute Gene Expression Assays Based on EraGen Technology

Mar 09, 2004

NEW YORK, March 9 (GenomeWeb News) - Promega and EraGen Biosciences have entered a distribution partnership that gives Promega exclusive rights to quantitative gene expression assays using technology developed by EraGen.

Promega has global distribution rights for the assays. Promega will develop and manufacture reagent systems in its Madison, Wis., facility, while EraGen will provide its patented chemistry and proprietary software for nucleic acid detection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Helix Launches 'App Store'

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

More CAR-T Therapies Sought

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Telomeres of Spawning Salmon

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

This Week in PLOS

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.

Main menu